CA1171404A - Derives de la cephalosporine, procede de preparation et composes les contenant - Google Patents

Derives de la cephalosporine, procede de preparation et composes les contenant

Info

Publication number
CA1171404A
CA1171404A CA000387048A CA387048A CA1171404A CA 1171404 A CA1171404 A CA 1171404A CA 000387048 A CA000387048 A CA 000387048A CA 387048 A CA387048 A CA 387048A CA 1171404 A CA1171404 A CA 1171404A
Authority
CA
Canada
Prior art keywords
formula
cephem
compound
group
methoxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000387048A
Other languages
English (en)
Inventor
Hideo Nakao
Sadao Ishihara
Shinichi Sugawara
Koichi Fujimoto
Isamu Igarashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55136449A external-priority patent/JPS5759894A/ja
Priority claimed from JP5523181A external-priority patent/JPS57169489A/ja
Priority claimed from JP8911681A external-priority patent/JPS57206687A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of CA1171404A publication Critical patent/CA1171404A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000387048A 1980-09-30 1981-09-30 Derives de la cephalosporine, procede de preparation et composes les contenant Expired CA1171404A (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP55136449A JPS5759894A (en) 1980-09-30 1980-09-30 Cephalosporin for oral administration
JP136449/80 1980-09-30
JP55231/81 1981-04-13
JP5523181A JPS57169489A (en) 1981-04-13 1981-04-13 Cephalosporin derivative and its preparation
JP8911681A JPS57206687A (en) 1981-06-10 1981-06-10 Cephalosporin derivative and its preparation
JP89116/81 1981-06-10

Publications (1)

Publication Number Publication Date
CA1171404A true CA1171404A (fr) 1984-07-24

Family

ID=27295533

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000387048A Expired CA1171404A (fr) 1980-09-30 1981-09-30 Derives de la cephalosporine, procede de preparation et composes les contenant

Country Status (11)

Country Link
US (2) US4486425A (fr)
EP (1) EP0049118B1 (fr)
KR (1) KR870000848B1 (fr)
AU (1) AU547984B2 (fr)
CA (1) CA1171404A (fr)
DE (1) DE3174472D1 (fr)
ES (4) ES8302002A1 (fr)
FI (1) FI73440C (fr)
IE (1) IE53177B1 (fr)
NL (1) NL930098I2 (fr)
PH (1) PH18740A (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) * 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
JPH01230547A (ja) * 1988-01-14 1989-09-14 Takeda Chem Ind Ltd ３−オキソ酪酸第三ブチルの製造法及びその用途
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8809534D0 (en) * 1988-04-22 1988-05-25 Beecham Group Plc Novel compounds
DE3901405A1 (de) * 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
DE59209994D1 (de) * 1991-09-07 2004-04-29 Aventis Pharma Gmbh Diastereomer des 3-Cephem-4-carbonsäure-1-(-isopropoxycarbonyloxy)ethylesters und Verfahren zu dessen Herstellung
TW212181B (fr) * 1992-02-14 1993-09-01 Hoechst Ag
ES2117066T3 (es) * 1992-05-21 1998-08-01 Hoechst Ag Procedimiento para la disociacion de esteres profarmacos de cefalosporina para dar acido 7-amino-3-metoximetil-cef-3-em-4-carboxilico.
LT3870B (en) 1993-11-30 1996-04-25 Hoechst Ag Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
AT413383B (de) 1998-01-09 2006-02-15 Sandoz Ag Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil
AT408226B (de) 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
IN191496B (fr) * 1999-07-30 2003-12-06 Ranbaxy Lab Ltd
KR100342944B1 (ko) * 1999-11-08 2002-07-02 민경윤 고순도 세프포독심 프록세틸의 제조방법
ATE303149T1 (de) * 2001-02-27 2005-09-15 Ranbaxy Lab Ltd Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
WO2002068429A1 (fr) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Procede de preparation de cefpodoxime proxetil
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
WO2004048387A1 (fr) * 2002-11-22 2004-06-10 Orchid Chemicals & Pharmaceuticals Ltd Procede ameliore pour la preparation de cefpodoxime proxetil
WO2004056834A1 (fr) * 2002-12-20 2004-07-08 Lupin Limited Procede pour preparer du cefpodoxime proxetil
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds
US20040242863A1 (en) * 2003-05-27 2004-12-02 Carenini Alessandro Riccardo Preparation of cefalosporins intermediates and conversion of said intermediates into active compound precursors
WO2010097675A1 (fr) 2009-02-27 2010-09-02 Dhanuka Laboratories Ltd. Procédé de préparation amélioré pour le cefpodoxime proxétil
TR201002878A2 (tr) 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil içeren farmasötik bileşimler.
WO2011152808A1 (fr) 2010-06-03 2011-12-08 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique
WO2011152807A1 (fr) 2010-06-03 2011-12-08 Bilgic Mahmut Préparations pharmaceutiques comprenant du cefpodoxime proxetil et de l'acide clavulanique
TR201007106A1 (tr) 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil formülasyonları.
TR201007107A1 (tr) 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201009168A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Suda dağılan sefpodoksim proksetil formülasyonları.
EP2520578A1 (fr) 2011-05-06 2012-11-07 Lupin Limited Procédé pour la purfication de céphalosporines
EP2758407A1 (fr) 2011-09-20 2014-07-30 Dhanuka Laboratories Ltd. Procédé perfectionné pour l'obtention de cefpodoxime sous forme acide
WO2013151517A1 (fr) 2012-04-04 2013-10-10 Mahmut Bilgic Formulations en comprimés comprenant du cefpodoxime proxétil et de l'acide clavulanique
WO2014123500A1 (fr) 2013-02-11 2014-08-14 Bilgiç Mahmut Formulations pharmaceutiques contenant du cefpodoxime proxétil et de l'acide clavulanique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760484C2 (fr) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
DE2714880A1 (de) 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
NL930098I2 (nl) 1995-02-01
NL930098I1 (nl) 1993-10-01
US4486425A (en) 1984-12-04
US4716158A (en) 1987-12-29
FI73440C (fi) 1987-10-09
ES505923A0 (es) 1982-12-16
KR830007685A (ko) 1983-11-04
EP0049118A3 (en) 1983-01-19
IE812273L (en) 1982-03-30
IE53177B1 (en) 1988-08-17
KR870000848B1 (ko) 1987-04-25
ES8302002A1 (es) 1982-12-16
EP0049118B1 (fr) 1986-04-23
ES514994A0 (es) 1983-05-01
ES8306158A1 (es) 1983-05-01
EP0049118A2 (fr) 1982-04-07
AU7578181A (en) 1982-04-08
FI813038L (fi) 1982-03-31
PH18740A (en) 1985-09-16
AU547984B2 (en) 1985-11-14
ES514995A0 (es) 1983-06-01
FI73440B (fi) 1987-06-30
ES8306759A1 (es) 1983-06-01
ES8306159A1 (es) 1983-05-01
DE3174472D1 (en) 1986-05-28
ES514993A0 (es) 1983-05-01

Similar Documents

Publication Publication Date Title
CA1171404A (fr) Derives de la cephalosporine, procede de preparation et composes les contenant
US4278671A (en) 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporins
CA1127633A (fr) Cephalosporine
US4279818A (en) Syn-isomers of 7-[2-alkoxyimino-2-(2-amino-thiazol-4-yl)acetamido]-3-[nitrobenzoyl-, or benzoyl-oxymethyl]-3-cephem-4-carboxylic acid
US4380541A (en) Cephalosporin derivatives
FR2474034A2 (fr) Nouvelles oximes 0-substituees derivees de l'acide 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
CA1172248A (fr) Derives de la cephalosporine, procede de preparation et composes les contenant
EP0376724A2 (fr) Dérivés de céphalosporines
US4399132A (en) 7-Beta-[alpha-syn-methoxyimino-alpha-(2-aminothiazol-4-yl)-acetamido]-3-[(1,2,3-thiadiazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid and C1 -C6 alkyl derivatives thereof
CA1102307A (fr) Traduction non-disponible
US4287193A (en) Syn isomers of 7-[2-(2-amino-4-thiazolyl)-2-(carboxymethyloxyimino)-acetamido]-ceph-3-eme-4-carboxylic acid compounds
BE853545A (fr) Nouveaux derives cephalosporines ayant un nouveau groupe 7-acyle et leur procede de fabrication
FR2461713A1 (fr) Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4331664A (en) Syn isomer of 7-[2-cyclo(lower) alkoxyimino-2-(2-amino-or substituted aminothiazol-4-yl)acetamido]-3-lower alkanoyloxymethyl or heterocyclicthiomethyl-3-cephem-4-carboxylic acid compounds
US4018921A (en) Substituted phenylglycylcephalosporins
US4364943A (en) Syn-isomer of 7-[2-alkoxyimino-2-(2-amino-alkanoylamino-or haloalkanoylamino-thiazol-4-yl) acetamids]-3-[hexanoyl-, or phenylalkanoyl-oxymethyl or benzothiazolylthiomethyl]-3-cephem-4-carboxylic acid
US4092480A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US4374834A (en) Novel compounds
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
US4022895A (en) Substituted phenylglycylcephalosporins
JP2002332288A (ja) セファロスポリン化合物、その用途およびその中間体化合物
US4013764A (en) Pharmaceutical compositions comprising substituted phenylglycylcephalosporins and methods of treating bacterial infections
DE2760488C2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
FR2532936A1 (fr) Nouveaux derives de l'acide 2-amino-thiazolyl-4-yl acetique comportant une fonction oxime substituee et leur procede de preparation
DE2404592A1 (de) Antibakterielle mittel und deren herstellung

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry